{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:44:41Z","timestamp":1789998281916,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.urolonc.2008.12.017","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T05:34:31Z","timestamp":1236663271000},"page":"520-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Priscila M.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daher C.","family":"Chade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo C.","family":"Borra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan P.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola E.","family":"Villanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana C.C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Srougi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2008.12.017_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1464-410X.1998.00720.x","article-title":"Bacille Calmette-Guerin in superficial transitional cell carcinoma","volume":"82","author":"Mungan","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: 10-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"The J Urol"},{"issue":"Suppl 3","key":"10.1016\/j.urolonc.2008.12.017_bib6","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1086\/314065","article-title":"Role of animal models in understanding intravesical therapy with bacille Calmette-Guerin","volume":"31","author":"Ratliff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urolonc.2008.12.017_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/01.ju.0000103924.93206.93","article-title":"Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine","volume":"171","author":"Lee","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.2004.02522.x","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity","volume":"137","author":"Luo","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib10","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2008.12.017_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C{T}) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego)"},{"key":"10.1016\/j.urolonc.2008.12.017_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(98)00028-3","article-title":"A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity","volume":"213","author":"Nociari","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.urolonc.2008.12.017_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.urolonc.2008.12.017_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.ju.0000109742.88380.a2","article-title":"Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: Dose-dependent tumor eradication and generation of protective immunity","volume":"171","author":"O'Donnell","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.157.1.12","article-title":"IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-\u03b1","volume":"157","author":"Daftarian","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2008.12.017_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2006.03191.x","article-title":"Role of Th1-stimulating cytokines in bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells","volume":"146","author":"Luo","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.urolonc.2008.12.017_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1586\/14737140.8.7.1091","article-title":"Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer","volume":"8","author":"Bruins","year":"2008","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908003888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908003888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:55:56Z","timestamp":1761040556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143908003888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1078143908003888"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.12.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}